NIAID News @NIAIDNews Twitter profile

Pinned Tweet

NIAID News

1 year

. @NIAIDNews is the official Twitter profile for information from the National Institute of Allergy and Infectious Diseases, part of NIH. You can verify all official NIAID social media channels here:

Connect with NIAID

NIAID utilizes digital communications tools such as websites and social media to reach various audiences.

www.niaid.nih.gov

19

5

19

Last Seen Profiles

@Love_423_Life

@ByClaytonDavis

@SamiSam63443526

@_y_a_e___

@Tjozenny31

@saudi7788991

@dprbunn

@Yotsubafour4

@2EZ_Techi

@westcoastscot

@LeoMKofficial

@RusSwole

@cuntycakes123

@delinquentweet

@spring8pr

@advisorynest

@cocosKitchensub

@bmdurg

@BrumBrumEspana

@moleiraaberta

@SafeTreasury

@charlotterlynch

@Ufficiale1st

@francebleuDA

@braverangels

@speergruesse

@tmstudio_

@xrp_cc

@SarahArriola4

@_jaytovah

@stpatricksgaa

@MaccaFrank

@ChannelYurufuwa

@new_einstein

@Ururi_Rapis

@farmerreborn

NIAID News

@NIAIDNews

1 year

COVID NEWS: Autopsies of people who died from COVID19 show that the virus spread throughout the body and remained in tissue for months. The study broadened scientists’ perspectives on where SARS-CoV-2 could cause infection and persist, including the brain.

120

2K

4K

NIAID News

@NIAIDNews

1 year

COVID-19 NEWS: #SARSCoV2 infection weakens a key immune cell’s response to vaccination with the Pfizer-BioNTech #COVID19 vaccine, suggesting a need to boost this response after infection, #NIAID grantees report: #immunology #Tcells @StanfordMed

212

841

2K

NIAID News

@NIAIDNews

4 years

COVID-19 NEWS: A preliminary data analysis from #NIH clinical trial shows hospitalized patients w/ advanced #COVID19 and lung involvement who received the investigational antiviral #remdesivir recovered faster than similar patients who received placebo:

56

543

885

NIAID News

@NIAIDNews

3 years

NIAID Director, Dr. Anthony Fauci will be rolling up his sleeve tomorrow to get @moderna_tx #COVID19 vaccine alongside @SecAzar , @NIHDirector , and several @NIHClinicalCntr frontline workers to build confidence in the vaccine, which is the best hope against this pandemic.

68

183

860

NIAID News

@NIAIDNews

5 years

A2: #Vaccines are important for people of all ages. The more people in a given population who are vaccinated for a disease, the less likely that disease will spread. This is called “herd immunity,” and it helps protect people who can’t get vaccines. #HHSVaxChat

16

617

828

NIAID News

@NIAIDNews

4 years

Mask up! We can all do our part to prevent the spread of #COVID19 ! Thanks to our friends at @USSoccer for these great masks made from national team jerseys! @uswnt @usmnt @AbbyWambach @CobiJones @kammarmanMNT @GeorgeChiampas

22

131

826

NIAID News

@NIAIDNews

4 years

NEWS: @EmoryUniversity in Atlanta will begin enrolling healthy adult volunteers in a Phase 1 clinical trial of a vaccine designed to prevent #coronavirus disease. The trial began in Seattle last week & will enroll a total of 45 people across the 2 sites:

13

255

373

NIAID News

@NIAIDNews

4 years

VOLUNTEERS NEEDED: The NIH Vaccine Research Center is looking for volunteers to donate blood for studies on the immune system. Participants will be compensated for their time and convenience. To volunteer, call 1-866-833-5433 (TTY 1-866-411-1010) or email vaccines @nih .gov.

8

348

335

NIAID News

@NIAIDNews

4 years

NEWS: NIAID labs have produced images of the #NovelCoronavirus SARS-CoV-2 🔬 Check out more images on #NIAIDNow : #SARSCoV2 #COVID19 #coronavirus

14

177

292

NIAID News

@NIAIDNews

4 years

#COVID19 NEWS: An #NIH -funded study on the incidence of novel #coronavirus infection in U.S. children has begun. The study also will examine whether infection rates differ between children who do & do not have #asthma or other #allergic conditions.

11

135

231

NIAID News

@NIAIDNews

4 years

NEWS: NIAID study shows antiviral #remdesivir prevents disease progression in monkeys with #COVID19 .

8

103

210

NIAID News

@NIAIDNews

5 years

NEWS: The science is clear: With #HIV , #undetectable equals #untransmittable . #NIAID experts discuss the scientific evidence & principles underlying #UEqualsU in @JAMA_current .

11

113

187

NIAID News

@NIAIDNews

4 years

NEWS: New data shows mRNA-1273, an investigational vaccine developed by #NIAID and @moderna_tx , protects mice from infection with #SARSCoV2 . The findings are available on the preprint server bioRxiv and are not yet peer-reviewed.

10

75

172

NIAID News

@NIAIDNews

1 year

NEWS: Dr. Fauci reflects on the perpetual challenge of infectious diseases in a new commentary in @NEJM .

3

44

167

NIAID News

@NIAIDNews

4 years

NEWS: NIH has begun a clinical trial to evaluate the safety and efficacy of the investigational antiviral #remdesivir in hospitalized adults diagnosed with #COVID19 .

8

92

151

NIAID News

@NIAIDNews

4 years

COVID-19 NEWS: @LJIResearch scientists have identified robust T cell responses to #SARSCoV2 in people who have recovered from #COVID19 , according to @NIH -supported research published today in @CellPress :

9

77

154

NIAID News

@NIAIDNews

6 years

NIAID-funded scientists identify new #SARS -like #coronavirus from bats in China, devastates young swine.

61

101

118

NIAID News

@NIAIDNews

4 years

#COVID19 NEWS: @NIH begins study to quantify undetected cases of #coronavirus infection. Blood samples from healthy volunteers are needed to inform public health decision making. Read more: 📸: @NIBIBgov

13

111

151

NIAID News

@NIAIDNews

6 years

NEWS: An experimental #HIVvaccine regimen elicited antibodies in mice, guinea pigs and monkeys that neutralize dozens of #HIV strains from around the world. Learn more: #NIH #NIAID

6

86

144

NIAID News

@NIAIDNews

2 years

NEWS: Dr. Fauci announced today that he will be stepping down in Dec. 2022 from the positions of NIAID Director and Chief of the NIAID Laboratory of Immunoregulation, as well as the position of Chief Medical Advisor to President Joe Biden.

Statement by Anthony S. Fauci, M.D.

I am announcing today that I will be stepping down from the positions of Director of the National Institute of Allergy and Infectious Diseases (NIAID) and Chief of the NIAID Laboratory of Immunoreg...

www.niaid.nih.gov

76

74

145

NIAID News

@NIAIDNews

5 years

Powerful #HIV prevention and treatment tools can help us end the U.S. HIV epidemic. Science has laid the groundwork for this bold new initiative. #SOTU

5

91

133

NIAID News

@NIAIDNews

2 years

The Epstein-Barr virus, the key cause of mononucleosis and linked to some cancers and autoimmune diseases, is the target of a new early-stage NIAID vaccine trial. Read more:

5

46

132

NIAID News

@NIAIDNews

2 years

COVID-19 NEWS: A @NIAIDNews -supported study has found that most #COVID19 vaccine-elicited T-cell responses to #SARSCoV2 recognize all variants of concern in adults up to 7 months after vaccination.

SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from...

Human memory T cells induced by SARS-CoV-2 vaccines maintain the ability to recognize viral variants, including the Omicron variant.

www.cell.com

3

58

130

NIAID News

@NIAIDNews

3 years

FLU NEWS: A nanoparticle #flu #vaccine that could deliver lasting protection from many flu strains has entered early-stage human trial at #NIH . The investigational vaccine, FluMost-v1, was developed by scientists from the #NIAID Vaccine Research Center.

12

45

124

NIAID News

@NIAIDNews

4 years

NEWS: An engineered antibody derived from llama antibodies may neutralize #SARSCoV2 , the virus that causes #COVID19 , report researchers at NIAID, @TexasScience & @ResearchUGent 🦙Further research into these proteins may help scientists find new treatments:

18

61

124

NIAID News

@NIAIDNews

4 years

#COVID19 News: A @NIAIDNews -funded study published in @ScienceMagazine has found that memory T cells are the source of pre-existing reactivity against #SARSCoV2 , explaining how some people who have never been exposed to the virus have reactivity to it.

5

67

118

NIAID News

@NIAIDNews

4 years

#TB NEWS: A new 4-month daily treatment regimen is as safe & effective as the standard 6-month regimen at curing drug-susceptible #tuberculosis disease, finds study led by @CDCgov w/ collaboration from @NIAIDNews @ACTGNetwork . #UnionConf

4

58

118

NIAID News

@NIAIDNews

4 years

COVID19 NEWS: Early results of #NIAID -sponsored ph1 trial of experimental #SARSCOV2 vaccine mRNA-1273: two doses generally well tolerated and prompted a robust immune response in healthy adults.

3

61

114

NIAID News

@NIAIDNews

4 years

LIVE at 1PM ET (3/26): On @Instagram Live, #NIH ’s @NIAIDNews Director #DrFauci talks with @StephenCurry30 about #COVID19 and how to #StaySafe ! Check out the NIAID Instagram for more info: #coronavirus #SCASKSFAUCI

11

68

114

NIAID News

@NIAIDNews

4 years

LIVE Tomorrow (3/26): On @Instagram Live, #NIH ’s @NIAIDNews Director #DrFauci talks with @StephenCurry30 about #COVID19 and how to #StaySafe ! Check out the NIAID Instagram for more info: #coronavirus #SCASKSFAUCI

7

61

107

NIAID News

@NIAIDNews

5 years

This #WorldAIDSDay , @NIAIDNews Director Dr. Anthony Fauci & @NIH_OAR Director Dr. Maureen Goodenow reflect on remarkable progress being made against #HIV —including antibodies, #PrEP , #UequalsU , vaccine studies, #TB coinfection & #transplantation : #WAD2018

2

77

103

NIAID News

@NIAIDNews

4 years

#CORONAVIRUS BLOG: Experimental #coronavirus vaccine delivered by a microneedle patch shows promise in early animal study. #NIAIDNow blog has more

35

55

106

NIAID News

@NIAIDNews

4 years

NEWS: #Remdesivir improves time to recovery for people hospitalized with #COVID19 , according to a peer-reviewed preliminary analysis published today in @NEJM . The results are from the #NIH randomized, placebo-controlled trial that began on Feb. 21

5

64

97

NIAID News

@NIAIDNews

3 years

#HIV NEWS: Long-acting injectable #cabotegravir prevents HIV acquisition among cisgender women, @NIAIDNews -sponsored study finds. The long-acting #PrEP regimen was safe & more effective than daily oral PrEP among African women.

1

56

98

NIAID News

@NIAIDNews

3 years

COVID-19 NEWS: Dr. Fauci explains the story behind #COVID19 vaccines in @ScienceMagazine

16

42

96

NIAID News

@NIAIDNews

1 year

COVID NEWS: Two NIAID studies highlight COVID19 nasal vaccine potential. Single dose delivered to nose aims to protect children, adults.

15

43

96

NIAID News

@NIAIDNews

4 years

NEWS: NIAID scientists describe a new approach that can rapidly identify receptor proteins that #coronaviruses —like #SARSCoV2 , the virus that causes #COVID19 —use to infect cells: @NatureMicrobiol

3

54

94

NIAID News

@NIAIDNews

4 years

NEWS: @NIH scientists have identified the atomic structure of the novel #coronavirus ( #SARSCoV2 , formerly #2019nCoV ). The findings appear in the peer-reviewed journal @ScienceMagazine & may aid in the design of candidate vaccines, treatments for #COVID19 :

2

59

92

NIAID News

@NIAIDNews

2 years

MONKEYPOX NEWS: In the coming weeks, #NIAID plans to initiate clinical trials evaluating the antiviral tecovirimat (TPOXX) for #monkeypox and a clinical trial evaluating dose-sparing regimens of JYNNEOS, a vaccine approved to prevent monkeypox. Read more

7

48

90

NIAID News

@NIAIDNews

3 years

COVID-19 NEWS: Neutralizing antibody activity against all variants of #SARS -CoV-2, including Delta, lasted 6 months in people who got 2 doses of #COVID19 mRNA #vaccine . Findings online now @ScienceMagazine

14

42

89

NIAID News

@NIAIDNews

3 years

NEWS: Most people who recover from #COVID19 develop robust #ImmuneMemory against #SARSCoV2 that lasts for at least 6 to 8 months, suggests a @NIAIDNews -funded study published in @ScienceMagazine .

2

41

88

NIAID News

@NIAIDNews

3 years

COVID-19 NEWS: College students can enroll in a study designed to determine if Moderna’s vaccine can prevent #SARSCoV2 infection, limit amount of virus in the nose & reduce transmission of SARS-CoV-2 from those vaccinated to their close contacts.

8

43

82

NIAID News

@NIAIDNews

5 months

NIAID scientists identify interferon-gamma as potential #SARSCoV2 antiviral:

6

35

68

NIAID News

@NIAIDNews

3 years

MALARIA NEWS: One dose of a new monoclonal antibody discovered and developed at @NIAIDNews safely prevented #malaria for up to nine months in people who were exposed to the #Plasmodium parasite. The finding was published online yesterday in @NEJM .

3

31

76

NIAID News

@NIAIDNews

2 years

MONKEYPOX NEWS: A clinical trial evaluating the antiviral #TPOXX ( #tecovirimat ) is now enrolling adults and children with #monkeypox in the U.S. #NIAID is conducting the trial in collaboration with @ACTGNetwork

5

19

51

NIAID News

@NIAIDNews

3 years

COVID-19 NEWS: volunteers who received two doses of the @moderna_tx #COVID19 vaccine in spring 2020 as part of an #NIH -led Phase 1 trial retained high levels of antibodies 6 months after the second dose, according to new data published in @NEJM today.

NEJM

@NEJM

3 years

33 participants who received both doses of the Moderna mRNA-1273 vaccine had blood drawn over 6 months after vaccination. #SARSCoV2 neutralizing activity was maintained in all the patients. A half-life of 202 days was determined for the live-virus neutralization activity.

17

352

729

1

35

74

NIAID News

@NIAIDNews

2 years

16

18

72

NIAID News

@NIAIDNews

1 year

#RSV NEWS: NIAID research played major role in development of first FDA-approved RSV #vaccine . Learn more:

6

21

74

NIAID News

@NIAIDNews

5 years

Universal flu vaccine news: #NIAID -funded scientists developed a novel anti- #flu antibody derived from llamas that could protect against a variety of #influenza A & B viruses

1

40

67

NIAID News

@NIAIDNews

1 year

Eczema News: #NIAID scientists have found a link between widely used chemicals called diisocyanates and #eczema . They’ve also showed that skin bacteria exposed to isocyanate stop producing oils necessary for skin to stay healthy. Read more:

4

18

72

NIAID News

@NIAIDNews

6 years

NEWS: One-month #tuberculosis prophylaxis is as effective as nine-month regimen for people living with #HIV , according to results from a #NIAID -funded #ClinicalTrial presented at #CROI2018 .

1

76

69

NIAID News

@NIAIDNews

4 years

NEWS: NIAID scientists show investigational chimp adenovirus #MERSCoV vaccine protects monkeys; #COVID19 study under way.

2

28

65

NIAID News

@NIAIDNews

3 years

#VACCINE NEWS: mRNA vaccines may someday shield us from more than #COVID19 : In an NIAID-supported study published in @ScienceMagazine last week, mRNA vaccines protected mice from viruses with pandemic potential.

Science Magazine

@ScienceMagazine

3 years

A new study shows that mRNA vaccines designed to express chimeric spike protein protect aged mice against epidemic, zoonotic, and pandemic SARS-like viruses. @David_RMartinez @Baric_Lab

6

95

304

6

21

69

NIAID News

@NIAIDNews

4 years

A Phase 3 clinical trial of the investigational mRNA-1273 vaccine for #COVID19 has begun. The vaccine was co-developed by @moderna_tx and #NIAID scientists. The trial will enroll 30,000 adult volunteers at nearly 90 sites in the US

3

33

67

NIAID News

@NIAIDNews

4 years

#COVID19 NEWS: #NIAID Director Dr. Fauci and @CDCDirector Dr. Redfield comment on challenges in addressing novel #coronavirus in new @NEJM editorial.

20

32

68

NIAID News

@NIAIDNews

6 years

Antibody and immune stimulant treatment for #HIV delayed viral rebound in half of treated monkeys for over 6 months, NIH-supported scientists announce at #CROI2018 . The treatment may also target viral reservoir, with implications for HIV remission research

2

58

69

NIAID News

@NIAIDNews

7 months

A clinical trial of a novel #HIV #vaccine is now taking place in the United States and South Africa. The vaccine includes technology developed with #NIAID support since 2004. Read about the study, HVTN 142: @Vir_Biotech @HelpEndHIV @gatesfoundation

5

21

65

NIAID News

@NIAIDNews

5 years

Challenge accepted, @CDCDirector ! NIAID Director Dr. Fauci stays #hearthealthy by going for runs on the NIH campus, and he encourages others to take daily walk or run breaks. He challenges Dr. Richard Hodes of @Alzheimers_NIH to take the #OurHearts pledge. #heartmonth

4

13

64

NIAID News

@NIAIDNews

4 years

It’s starting now! #coronavirus #COVID19 #SCASKSFAUCI @stephencurry30

NIAID News

@NIAIDNews

4 years

LIVE at 1PM ET (3/26): On @Instagram Live, #NIH ’s @NIAIDNews Director #DrFauci talks with @StephenCurry30 about #COVID19 and how to #StaySafe ! Check out the NIAID Instagram for more info: #coronavirus #SCASKSFAUCI

11

68

114

23

16

60

NIAID News

@NIAIDNews

1 year

INFLUENZA NEWS: Scientists at NIAID’s #Vaccine Research Center report in two new studies that an experimental #influenza vaccine, designed to protect against a broad range of flu viruses, performed well in a Phase 1 trial and has advanced to a second trial

3

19

64

NIAID News

@NIAIDNews

1 year

FLU NEWS: An mRNA vaccine candidate designed to protect against all known influenza virus subtypes shows promise in preclinical studies, according to a new report by NIAID-supported researchers @PennMedicine published in @ScienceMagazine .

5

14

63

NIAID News

@NIAIDNews

5 years

🎥: The plan to end the #HIV epidemic in the U.S. targets resources to the geographic areas most affected by HIV. @CarlosdelRio7 of @EmoryCFAR discusses the importance of #CommunityEngagement in #HIVResearch .

1

25

63

NIAID News

@NIAIDNews

8 months

NIAID's influenza research program is working to develop a universal flu vaccine to provide robust, long-lasting protection against multiple subtypes of flu. A #UniversalFluVaccine would eliminate the need to update & administer the seasonal flu vaccine each year. #NIAM

5

16

61

NIAID News

@NIAIDNews

4 years

HIV NEWS: A vaginal ring for #HIV prevention has received a positive opinion from @EMA_News for use by cisgender women in developing countries! @NIAIDNews celebrates this pivotal step toward expanding #HIVprevention choices for women. #WomensHealth

4

39

58

NIAID News

@NIAIDNews

2 years

August is National Immunization Awareness Month! This month, we will be sharing information about #vaccines that NIAID has helped develop and trials that are ongoing to evaluate potential vaccines. #ivax2protect #NIAM2022

1

32

59

NIAID News

@NIAIDNews

5 years

NEWS: #NIH and partners to launch phase 3 #HIV vaccine efficacy trial in the Americas and Europe.

7

37

53

NIAID News

@NIAIDNews

7 years

NEWS: 3-in-1 antibody protects monkeys from #HIV -like virus; scientists prepare to test antibody in people

3

41

55

NIAID News

@NIAIDNews

4 years

COVID-19 NEWS: The disease spread by a novel #coronavirus is causing worldwide disruption. How did we get here, and can swift public health actions prevent a #pandemic ? #NIAID scientists offer perspective: #COVID19

Escaping Pandora’s Box — Another Novel Coronavirus | NEJM

With luck, public health control measures may be able to put the Covid-19 demons back in the jar. If they do not, we face a daunting challenge equal to, or perhaps greater than, that posed by the ...

www.nejm.org

7

29

58

NIAID News

@NIAIDNews

4 years

NEWS: #NIAID funds new global research network to study emerging #InfectiousDiseases including #COVID19 .

NIAID Establishes Centers for Research in Emerging Infectious Diseases

The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, today announced that it has awarded 11 grants with a total first-year value of approxima...

www.niaid.nih.gov

1

19

55

NIAID News

@NIAIDNews

9 months

COVID-19 NEWS: #NIAID researchers used mice to learn why some parasitic worm infections may confer resistance to severe #COVID19 . NIAID Now blog:

8

25

55

NIAID News

@NIAIDNews

2 years

#COVID19 NEWS: A new study demonstrates an association between high blood plasma antigen levels and worse patient outcomes in severe SARS-CoV-2 infections.

7

28

47

NIAID News

@NIAIDNews

5 years

Entertainer @JVN discussed #UEqualsU on @TODAYshow , explaining that people living with #HIV cannot pass on the virus if they maintain durable viral suppression. Learn more on #NIAIDNow :

4

28

52

NIAID News

@NIAIDNews

3 years

#COVID19 NEWS: @NIAIDNews research published in @CellCellPress finds some people experience a late “second wave” of immune responses to #SARSCoV2 infection that is associated with more severe disease & death.

1

28

54

NIAID News

@NIAIDNews

7 months

Today @NIH issued the Strategic Plan for #Herpes Simplex Virus (HSV) Research, developed by the NIH-wide #HSV Working Group and informed by feedback from 100+ research and advocacy community representatives and the public. Learn more:

8

18

54

NIAID News

@NIAIDNews

3 years

CORONAVIRUS NEWS: The NIH has awarded $36.3 million to three institutions to develop “pan-coronavirus” vaccines that protect against multiple coronaviruses AND variants.

20

24

52

NIAID News

@NIAIDNews

4 years

NIAID scientists at Rocky Mountain Laboratories rapidly identified human ACE2 as receptor #2019nCoV uses to infect human cells. #coronavirus

0

24

51

NIAID News

@NIAIDNews

3 years

#COVID19 NEWS: A @NIAIDNews trial is underway to find out if ppl who are highly #allergic or have a #MastCellDisorder are at increased risk for an immediate, systemic allergic reaction to the @moderna_tx or @pfizer @BioNTech_Group COVID-19 #vaccines .

5

26

52

NIAID News

@NIAIDNews

1 year

#FoodAllergy NEWS: A skin patch containing a very small amount of #peanut protein may become a safe new way to treat #PeanutAllergy in toddlers, #NIAID ’s Dr. Alkis Togias writes in an @NEJM editorial on the EPITOPE trial results: : #allergy #NIH

1

22

51

NIAID News

@NIAIDNews

4 years

VIDEO: @NIAIDNews Director Anthony S. Fauci says we have the scientific tools right now that—if properly implemented—could stop the #HIV epidemic in its tracks. The challenge is to overcome what he calls an “implementation gap.” #NIAID #NIH #Solvable

2

29

52

NIAID News

@NIAIDNews

2 years

March 24 is World Tuberculosis (TB) Day. TB is the second leading infectious killer in the world after COVID-19. During the coronavirus pandemic, reduced access to care interrupted TB control, resulting in more deaths.

1

20

52

NIAID News

@NIAIDNews

1 year

COVID19 NEWS: Randomized Phase 2 #COVAIL study compares two mRNA bivalent vaccine boosters. Findings highlight concerns SARS-CoV-2 virus evolution outpaces vaccine generated antibodies.

13

28

51

NIAID News

@NIAIDNews

2 years

A key focus of NIAID’s #influenza research program is developing a universal #flu vaccine---one that could protect against multiple flu subtypes and eliminate the need for an annual seasonal flu vaccine. Read more at #NIAM2022

5

17

38

NIAID News

@NIAIDNews

3 years

#COVID19 NEWS: #Tcells from recovered #COVID19 patients retain ability to recognize #SARSCoV2 variants. New peer-reviewed research from #NIAID and colleagues @immunoscape and @jhucovidplasma

3

29

50

NIAID News

@NIAIDNews

6 months

A study by @gardp_amr & @innovivastx found the novel antibiotic zoliflodacin was as safe & effective as standard therapy for uncomplicated urogenital #gonorrhea . #NIAID supported dev't of zoliflodacin & applauds partners on completing the study. Read more:

3

18

51

NIAID News

@NIAIDNews

4 years

NEWS: Dr. Fauci & colleagues note in @JAMA_current : a return to normalcy will require widespread adoption of masks & other interventions to prevent #SARSCoV2 spread (distancing; hand hygiene; testing, isolation & contact tracing; limiting crowds):

Preventing the Spread of SARS-CoV-2 With Masks and Other “Low-tech” Interventions

In this Viewpoint, Anthony Fauci and colleagues at NIAID emphasize the continued importance of low-tech public health practices, such as wearing masks, limiting large gatherings, hand washing, and...

jamanetwork.com

3

27

44

NIAID News

@NIAIDNews

2 months

4 children have remained free of detectable #HIV for more than 1 year after their #AntiretroviralTherapy was paused to see if they could achieve HIV remission. The #NIAID -sponsored study was presented at #CROI2024 . More: @IMPAACTNetwork @NICHD_NIH @NIMHgov

1

27

47

NIAID News

@NIAIDNews

4 years

#HIV NEWS: Long-acting injectable form of HIV #PrEP outperforms daily pill in @NIAIDNews study. Both methods were highly effective at preventing HIV among MSM and TGW, @HIVptn scientists report at #AIDS2020 .

1

35

44

NIAID News

@NIAIDNews

3 months

3 different #HIV #antibodies isolated by the #NIAIDVRC each protected monkeys from acquiring simian-HIV. The antibodies target the fusion peptide on HIV. Findings support continued development of this concept for an HIV #vaccine for people. Read more: #NIH

1

14

46

NIAID News

@NIAIDNews

3 years

COVID-19 NEWS: Today, two Phase 3 trials to test potential therapeutics for #COVID19 began enrolling participants. The two trials, part of the ACTIV-3 master protocol, will test monoclonal #antibody therapeutics in hospitalized participants.

1

17

45

NIAID News

@NIAIDNews

2 years

#COVID19 NEWS: Preliminary results of #NIAID -sponsored trial examining mRNA COVID-19 #vaccines containing #Omicron variant used as a second boost dose now posted as a pre-print:

6

16

44

NIAID News

@NIAIDNews

3 years

On #WorldAIDSDay , @NIH reflects on both the remarkable progress that has been made against #HIV & the considerable challenges that remain. Read a statement from @NIAIDNews Director Dr. Fauci & @NIH_OAR Director Dr. Goodenow:

1

19

44

NIAID News

@NIAIDNews

2 years

#FLU NEWS: #NIAID #ClinicalTrial of a nanoparticle flu #vaccine found it was safe and prompted an immune response. Such vaccines could one day provide long-lasting protection from many flu #virus subtypes.

2

9

43

NIAID News

@NIAIDNews

3 years

FLU NEWS: Tiny nanoparticles could make a huge impact in future, long-lasting #flu #vax . New research by #NIAID scientists and @UW colleagues

6

13

39

NIAID News

@NIAIDNews

2 years

COVID-19 vaccines available in the United States are effective at protecting people from getting seriously ill, being hospitalized, and even dying—especially people who are boosted. @CDCgov recommends that everyone 6 months and older get vaccinated against #COVID19 #NIAM2022

17

14

34

NIAID News

@NIAIDNews

3 years

COVID NEWS: NIAID scientists find experimental antiviral for #COVID19 effective in hamster study. MK-4482, also known as #molnupiravir and EIDD-2801, originally developed to treat influenza.

5

26

40

NIAID News

@NIAIDNews

5 years

BLOG: Today, on HIV Long-Term Survivors Awareness Day, @NIAIDNews & @nih_nhlbi renew their commitment to study #HIV disease across the lifespan and reduce chronic HIV-related co-morbidities. #HLTSAD2019 #empowered2thrive

0

25

40

NIAID News

@NIAIDNews

3 years

BLOG: January 30th is World Neglected Tropical Diseases (NTD) Day. Learn about how NIAID is helping to #EndTheNeglect of NTDs and supporting the global effort to prevent, control, and eliminate these diseases on the #NIAIDNow blog: #WorldNTDday #BeatNTDs

0

23

40

NIAID News

@NIAIDNews

1 year

#HIV News: A daily statin medication was found to reduce the risk of cardiovascular disease in people living with HIV: @NIAIDNews @nih_nhlbi @NIH_OAR @ACTGNetwork @MassGeneralNews @dukemedicine @Harvard #cvd

3

27

40

NIAID News

@NIAIDNews

5 months

On #WorldAIDSDay 35, NIAID remembers the many lives affected by the HIV pandemic and remains committed to collective efforts with research and community partners to end HIV for all. Read the NIH World AIDS Day statement:

3

17

29